Preliminary scientific tests suggest conolidine might inhibit specific ion channels, minimizing neuronal excitability and restricting agony signals. This system is especially suitable in neuropathic pain, where by irregular signaling will cause persistent distress. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathw